Scholarlink

Background <p>Patients with symptoms of acute coronary syndrome make up a significant proportion of emergency department (EDs) presentations. High-sensitivity troponin testing is a standard component of evaluating patients with suspected symptomatic coronary disease. We sought to synthesize the evidence of the accuracy of 0/2-h and 0/3-h algorithms using the Beckman Access high-sensitivity cardiac troponin I (hs-cTnI) assay.</p> Methods <p>We developed an electronic search strategy retrieving research from three electronic databases (Medline, Embase, and Wiley Cochrane Library). Relevant research studies were screened and data extracted by a team of reviewers. Study quality and risk assessment were appraised using the QUADAS-2 tool. Findings were reported according to PRISMA guidelines.</p> Results <p>Five studies met inclusion criteria. No studies directly compared the 0&#xa0;h/2&#xa0;h and 0&#xa0;h/3&#xa0;h algorithms using the Beckman Coulter Access hs-cTnI assay, and heterogeneity in study design precluded meta-analysis. Included studies variably used 2-h, 3-h, or intermediate timepoints for serial troponin measurement. All studies reported consistently high sensitivity (&gt; 97.7%) and NPV (&gt; 98.9%) for ruling out acute myocardial infarction, supporting the reliability of both 0/2&#xa0;h and 0/3&#xa0;h hs-cTnI algorithms in the ED.</p> Conclusions <p>Of the five studies included, two studies suggest that a two-hour hs-TnI algorithm can effectively rule out myocardial infarction with similar accuracy to a longer three-hour protocol. Use of a 2-h hs-cTnI algorithm may lead to operational gains compared to a 3-h serial testing algorithm.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Two- vs three-hour hs-cTnI algorithms for ruling out acute myocardial infarction using the Beckman access high-sensitivity cardiac troponin I: a systematic review

  • 期刊论文

  • 发表日期：

    2026年1月13日

查看全文
  • Angela Mak,
  • Yi Li Chen,
  • Inam Khalfan,
  • Rachel Zhao,
  • Safia Khalfan,
  • Michael D. Hill,
  • Andrew D. McRae

摘要

Background

Patients with symptoms of acute coronary syndrome make up a significant proportion of emergency department (EDs) presentations. High-sensitivity troponin testing is a standard component of evaluating patients with suspected symptomatic coronary disease. We sought to synthesize the evidence of the accuracy of 0/2-h and 0/3-h algorithms using the Beckman Access high-sensitivity cardiac troponin I (hs-cTnI) assay.

Methods

We developed an electronic search strategy retrieving research from three electronic databases (Medline, Embase, and Wiley Cochrane Library). Relevant research studies were screened and data extracted by a team of reviewers. Study quality and risk assessment were appraised using the QUADAS-2 tool. Findings were reported according to PRISMA guidelines.

Results

Five studies met inclusion criteria. No studies directly compared the 0 h/2 h and 0 h/3 h algorithms using the Beckman Coulter Access hs-cTnI assay, and heterogeneity in study design precluded meta-analysis. Included studies variably used 2-h, 3-h, or intermediate timepoints for serial troponin measurement. All studies reported consistently high sensitivity (> 97.7%) and NPV (> 98.9%) for ruling out acute myocardial infarction, supporting the reliability of both 0/2 h and 0/3 h hs-cTnI algorithms in the ED.

Conclusions

Of the five studies included, two studies suggest that a two-hour hs-TnI algorithm can effectively rule out myocardial infarction with similar accuracy to a longer three-hour protocol. Use of a 2-h hs-cTnI algorithm may lead to operational gains compared to a 3-h serial testing algorithm.